Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Jacobson

Showing results (51-60 of 243) with videos related to

Pageof 25
Sort By:
Expert Opinion on Drug Safety|August 9, 2003
The overall safety profile of currently available vaccines directed against infectious diseasesRobert M Jacobson, Kim S Zabel, Gregory A Poland
Vaccine|May 23, 2009
Testing vaccines in pediatric research subjectsRobert M Jacobson, Inna G Ovsyannikova, Gregory A Poland
The Journal of Pediatrics|May 19, 2009
Ethics in everyday pediatricsRobert M Jacobson, Ryan M Antiel, Philip R Fischer
Pharmacogenomics|May 20, 2009
Application of pharmacogenomics to vaccinesGregory A Poland, Inna G Ovsyannikova, Robert M Jacobson
Expert Review of Clinical Immunology|September 28, 2013
Parents' perceptions of the HPV vaccine: a key target for improving immunization ratesRobert M Jacobson, James R Roberts, Paul M Darden
Clinical and Translational Science|May 21, 2014
Human papillomavirus vaccination: a case study in translational scienceAllyson K Palmer, Antoneicka L Harris, Robert M Jacobson
Mayo Clinic Proceedings|September 28, 2015
Population Health as a Means for Health Care Organizations to Deliver ValueRobert M Jacobson, George J Isham, Lila J Finney Rutten
Vaccine|October 20, 2009
The social, political, ethical, and economic aspects of biodefense vaccinesGregory A Poland, Robert M Jacobson, Jon Tilburt, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 3, 2008
Characterization of the duration from onset of asthma symptoms to asthma diseaseMolly Martyn, Amy L Weaver, Robert M Jacobson, et al.
Mayo Clinic Proceedings|November 7, 2015
Vaccine HesitancyRobert M Jacobson, Jennifer L St Sauver, Lila J Finney Rutten
Pageof 25

Showing results (51-60 of 243) with videos related to

Sort By:
Pageof 25
Expert Opinion on Drug Safety|August 9, 2003
The overall safety profile of currently available vaccines directed against infectious diseasesRobert M Jacobson, Kim S Zabel, Gregory A Poland
Vaccine|May 23, 2009
Testing vaccines in pediatric research subjectsRobert M Jacobson, Inna G Ovsyannikova, Gregory A Poland
The Journal of Pediatrics|May 19, 2009
Ethics in everyday pediatricsRobert M Jacobson, Ryan M Antiel, Philip R Fischer
Pharmacogenomics|May 20, 2009
Application of pharmacogenomics to vaccinesGregory A Poland, Inna G Ovsyannikova, Robert M Jacobson
Expert Review of Clinical Immunology|September 28, 2013
Parents' perceptions of the HPV vaccine: a key target for improving immunization ratesRobert M Jacobson, James R Roberts, Paul M Darden
Clinical and Translational Science|May 21, 2014
Human papillomavirus vaccination: a case study in translational scienceAllyson K Palmer, Antoneicka L Harris, Robert M Jacobson
Mayo Clinic Proceedings|September 28, 2015
Population Health as a Means for Health Care Organizations to Deliver ValueRobert M Jacobson, George J Isham, Lila J Finney Rutten
Vaccine|October 20, 2009
The social, political, ethical, and economic aspects of biodefense vaccinesGregory A Poland, Robert M Jacobson, Jon Tilburt, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 3, 2008
Characterization of the duration from onset of asthma symptoms to asthma diseaseMolly Martyn, Amy L Weaver, Robert M Jacobson, et al.
Mayo Clinic Proceedings|November 7, 2015
Vaccine HesitancyRobert M Jacobson, Jennifer L St Sauver, Lila J Finney Rutten
Pageof 25